EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Therapy experience with ketoconazole: a new dermatologic powder preparation of 2%



Therapy experience with ketoconazole: a new dermatologic powder preparation of 2%



Giornale Italiano di Dermatologia E Venereologia 119(5): Xiii-Xxvi




(PDF emailed within 1 workday: $29.90)

Accession: 044795081

Download citation: RISBibTeXText

PMID: 6096265



Related references

Experiments in treatment using ketoconazole. A new 2% dermatological powder preparation. Giornale Italiano di Dermatologia e Venereologia 119(5): XIII-XVI, 1984

Experience with a new corticosteroid preparation, Apolar, for dermatologic use. Tidsskrift for den Norske Laegeforening 90(8): 770-771, 1970

Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome. Clinical Endocrinology 27(5): 593-599, 1987

Dermatologic side effects associated with gefitinib therapy: clinical experience and management. Clinical Lung Cancer 4(6): 366-369, 2003

Long term experience with high dose ketoconazole therapy for prostate cancer. Journal of Urology 135(4 PART 2): 201A, 1986

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. American Journal of Medicine 74(1B): 23-29, 1983

Effects of ketoconazole on the immune system. III. In vitro testing of ketoconazole and therapy follow-up in chronic dermatophytoses. Mycoses 31(1): 52-58, 1988

Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma. Journal of Urology 137(5): 902-904, 1987

Therapy of dermatologic disorders, including a guide to diagnosis and a dermatologic pharmacopeia. Therapy of dermatologic disorders, including a guide to diagnosis and a dermatologic pharmacopeia 383p, 1951

Effects of ketoconazole on the immune system. III. In vitro testing with ketoconazole and follow-up studies of therapy in chronic dermatophytoses. Mycoses 31(1): 52-58, 1988

Silicon oxide powder and process for manufacturing thereof, and cosmetic preparation, micelle holding powder, and perfume holding powder, using the same. Official Gazette of the United States Patent & Trademark Office Patents 1266(4), Jan 28, 2003

WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. Journal of Acquired Immune Deficiency Syndromes 62(3): E101-E103, 2013

The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer who can benefit from ketoconazole therapy?. 2012

Mediphon powder in dermatologic practice. Zeitschrift für Haut- und Geschlechtskrankheiten 43(17): 721-723, 1968

Powder-to-powder polycondensation of natural saccharides. Facile preparation of highly branched polysaccharides. Organic & Biomolecular Chemistry 3(9): 1746-1750, 2005